HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 12.52
-0.42 (-3.25%)
Jan 21, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.81 billion as of January 21, 2026. Its market cap has increased by 720.22% in one year.
Market Cap
10.81B
Enterprise Value
8.81B
Revenue
908.35M
Ranking
n/a
PE Ratio
17.89
Stock Price
12.52
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.81B, an increase of 27.80%. That is a compound annual growth rate of 4.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 10.81B | 6.35% |
| Dec 31, 2025 | 10.17B | 646.35% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 14.02B |
| Everest Medicines | 13.55B |
| Ascletis Pharma | 13.39B |
| Mirxes Holding Company | 11.61B |
| Shanghai Haohai Biological Technology | 10.81B |
| Nanjing Leads Biolabs | 10.44B |
| Lepu Biopharma | 9.53B |
| Abbisko Cayman | 9.33B |